Industry News! Gilead Drops $2.1B for Ouro, Hopes To Split Cost with Galapagos

Industry News! 'The perfect partner': Astellas, Vir engage in $1.7B deal for masked prostate cancer bispecific

Industry News! UCB enters TCE space with $1.1B deal for Chinese biotech's autoimmune candidate

Industry News! A California startup wins $180M in support as Sanofi rebuilds presence in T cell engagers

Industry News! Gilead bets $1.68B upfront on Ouro Medicines’ autoimmune program, with Galapagos expected to pitch in